Form 4: Arteris VP Sells Shares Under Pre-Arranged 10b5-1 Plan

Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, exercised options and sold 5,000 shares of common stock for a significant gain under a pre-arranged 10b5-1 trading plan.

Summary

• Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), reported transactions on February 2, 2026.
• Alpern exercised options to acquire 5,000 shares of common stock at an exercise price of $0.56 per share.
• Concurrently, 5,000 shares of common stock were sold at a weighted average price of $15.4753 per share, with individual sales ranging from $15.05 to $15.93.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Alpern on June 5, 2025.
• Following these reported transactions, Alpern directly beneficially owns 57,650 shares of common stock.
• Alpern also directly beneficially owns 65,000 derivative securities (options) after the reported transactions.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction executed under a pre-established 10b5-1 plan, which is a common practice for executives to manage their equity compensation. The significant profit realized by the insider is a positive for the individual, but the transaction itself provides no new material information regarding the company's operational performance or future outlook.

Positives

• The reporting person realized a significant financial gain by exercising options at $0.56 and selling the resulting shares at a weighted average price of $15.4753.
• The transaction was conducted under a pre-arranged 10b5-1 trading plan, which demonstrates a structured and compliant approach to managing equity compensation, mitigating concerns about opportunistic insider trading.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived by the market as a signal, though it is often a routine part of executive compensation and personal financial management.

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

StockSavvy.ai notes that transactions executed under Rule 10b5-1 trading plans are a standard practice for corporate insiders. These plans allow executives to pre-arrange sales of company stock at a future date, providing an affirmative defense against claims of insider trading and enabling systematic diversification or liquidity management.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders may interpret insider selling, even under a 10b5-1 plan, with varying degrees of concern, though the pre-planned nature typically mitigates negative sentiment.
• The transaction provides liquidity and financial benefit to the reporting executive.

Next Steps

• NA

Key Dates

Recommendation

The Form 4 filing details a pre-scheduled insider transaction under a 10b5-1 plan, which is a routine event for executives managing their equity compensation. It does not provide new fundamental information about the company's operations or future prospects that would alter an investment recommendation.

Keywords

Arteris, AIP, insider trading, Form 4, stock options, 10b5-1 plan, executive compensation, equity sales